Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean P Collins

Showing results (411-420 of 428) with videos related to

Pageof 43
Sort By:
Journal of the American College of Emergency Physicians Open|April 18, 2022
Troponin is unrelated to outcomes in heart failure patients discharged from the emergency departmentGregory J Fermann, Jon W Schrock, Phillip D Levy, et al.
Nature Medicine|March 1, 2022
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trialAdriaan A Voors, Christiane E Angermann, John R Teerlink, et al.
JAMA Cardiology|November 18, 2020
Effect of a Self-care Intervention on 90-Day Outcomes in Patients With Acute Heart Failure Discharged From the Emergency Department: A Randomized Clinical TrialSean P Collins, Dandan Liu, Cathy A Jenkins, et al.
JACC. Heart Failure|April 12, 2014
Developing therapies for heart failure with preserved ejection fraction: current state and future directionsJaved Butler, Gregg C Fonarow, Michael R Zile, et al.
European Journal of Heart Failure|May 30, 2020
Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of CardiologyOvidiu Chioncel, John Parissis, Alexandre Mebazaa, et al.
European Journal of Heart Failure|April 30, 2020
Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of CardiologyVeli-Pekka Harjola, John Parissis, Johann Bauersachs, et al.
European Journal of Heart Failure|May 4, 2025
Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Ovidiu Chioncel, Alexandre Mebazaa, Dimitrios Farmakis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 9, 2020
Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical controlRebecca G Levin-Epstein, Naomi Y Jiang, Xiaoyan Wang, et al.
Acute Cardiac Care|April 28, 2009
Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient-parts 1-6W Frank Peacock, Gregg C Fonarow, Douglas S Ander, et al.
Annals of the American Thoracic Society|June 4, 2020
Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19Jonathan D Casey, Nicholas J Johnson, Matthew W Semler, et al.
Pageof 43

Showing results (411-420 of 428) with videos related to

Sort By:
Pageof 43
Journal of the American College of Emergency Physicians Open|April 18, 2022
Troponin is unrelated to outcomes in heart failure patients discharged from the emergency departmentGregory J Fermann, Jon W Schrock, Phillip D Levy, et al.
Nature Medicine|March 1, 2022
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trialAdriaan A Voors, Christiane E Angermann, John R Teerlink, et al.
JAMA Cardiology|November 18, 2020
Effect of a Self-care Intervention on 90-Day Outcomes in Patients With Acute Heart Failure Discharged From the Emergency Department: A Randomized Clinical TrialSean P Collins, Dandan Liu, Cathy A Jenkins, et al.
JACC. Heart Failure|April 12, 2014
Developing therapies for heart failure with preserved ejection fraction: current state and future directionsJaved Butler, Gregg C Fonarow, Michael R Zile, et al.
European Journal of Heart Failure|May 30, 2020
Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of CardiologyOvidiu Chioncel, John Parissis, Alexandre Mebazaa, et al.
European Journal of Heart Failure|April 30, 2020
Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of CardiologyVeli-Pekka Harjola, John Parissis, Johann Bauersachs, et al.
European Journal of Heart Failure|May 4, 2025
Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Ovidiu Chioncel, Alexandre Mebazaa, Dimitrios Farmakis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 9, 2020
Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical controlRebecca G Levin-Epstein, Naomi Y Jiang, Xiaoyan Wang, et al.
Acute Cardiac Care|April 28, 2009
Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient-parts 1-6W Frank Peacock, Gregg C Fonarow, Douglas S Ander, et al.
Annals of the American Thoracic Society|June 4, 2020
Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19Jonathan D Casey, Nicholas J Johnson, Matthew W Semler, et al.
Pageof 43